anmelden
Stoxx Europe 50
5.500,53
PKT
-4,46
PKT
-0,08
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu Stoxx Europe 50-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 16.02.26 | SAFRAN Overweight | JP Morgan Chase & Co. | |
| 16.02.26 | SAFRAN Outperform | RBC Capital Markets | |
| 13.02.26 | UniCredit Buy | Goldman Sachs Group Inc. | |
| 13.02.26 | AB InBev SA-NV (Anheuser-Busch InBev) Buy | Goldman Sachs Group Inc. | |
| 13.02.26 | Novo Nordisk Equal Weight | Barclays Capital | |
| 13.02.26 | Hermès (Hermes International) Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 13.02.26 | RELX Outperform | Bernstein Research | |
| 13.02.26 | Siemens Energy Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 13.02.26 | AB InBev SA-NV (Anheuser-Busch InBev) Outperform | Bernstein Research | |
| 13.02.26 | LOréal Neutral | JP Morgan Chase & Co. | |
| 13.02.26 | LOréal Market-Perform | Bernstein Research | |
| 13.02.26 | SAFRAN Outperform | Bernstein Research | |
| 13.02.26 | Siemens Overweight | JP Morgan Chase & Co. | |
| 13.02.26 | UniCredit Overweight | JP Morgan Chase & Co. | |
| 13.02.26 | Santander Buy | Goldman Sachs Group Inc. | |
| 13.02.26 | RELX Buy | UBS AG | |
| 13.02.26 | AB InBev SA-NV (Anheuser-Busch InBev) Buy | UBS AG | |
| 13.02.26 | AstraZeneca Outperform | Bernstein Research | |
| 13.02.26 | GSK Buy | Jefferies & Company Inc. | |
| 13.02.26 | SAFRAN Neutral | UBS AG | |
| 13.02.26 | LOréal Overweight | Barclays Capital | |
| 13.02.26 | LOréal Buy | UBS AG | |
| 13.02.26 | RELX Overweight | Barclays Capital | |
| 13.02.26 | EssilorLuxottica Overweight | Barclays Capital | |
| 13.02.26 | AB InBev SA-NV (Anheuser-Busch InBev) Overweight | Barclays Capital | |
| 13.02.26 | Hermès (Hermes International) Neutral | UBS AG | |
| 13.02.26 | Siemens Underweight | Barclays Capital | |
| 13.02.26 | SAFRAN Buy | Goldman Sachs Group Inc. | |
| 13.02.26 | SAFRAN Buy | Jefferies & Company Inc. | |
| 13.02.26 | SAFRAN Outperform | RBC Capital Markets | |
| 13.02.26 | EssilorLuxottica Buy | Jefferies & Company Inc. | |
| 12.02.26 | AB InBev SA-NV (Anheuser-Busch InBev) Buy | Jefferies & Company Inc. | |
| 12.02.26 | LOréal Outperform | RBC Capital Markets | |
| 12.02.26 | Hermès (Hermes International) Neutral | JP Morgan Chase & Co. | |
| 12.02.26 | EssilorLuxottica Kaufen | DZ BANK | |
| 12.02.26 | Sanofi Neutral | JP Morgan Chase & Co. | |
| 12.02.26 | TotalEnergies Neutral | JP Morgan Chase & Co. | |
| 12.02.26 | EssilorLuxottica Overweight | JP Morgan Chase & Co. | |
| 12.02.26 | AB InBev SA-NV (Anheuser-Busch InBev) Overweight | JP Morgan Chase & Co. | |
| 12.02.26 | AstraZeneca Halten | DZ BANK |
